Product
Niacinamide
1 clinical trial
3 indications
Indication
Ischemia Reperfusion InjuryIndication
Myocardial InjuryIndication
Acute Kidney InjuryClinical trial
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury (NACAM) TrialStatus: Recruiting, Estimated PCD: 2025-04-30